Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 6.12
- Piotroski Score 5.00
- Grade Hold
- Symbol (PGNY)
- Company Progyny, Inc.
- Price $15.01
- Changes Percentage (7.33%)
- Change $1.03
- Day Low $13.92
- Day High $15.10
- Year High $42.08
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/25/2025
- Fiscal Year End N/A
- Average Stock Price Target $22.00
- High Stock Price Target $41.00
- Low Stock Price Target $18.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.61
- Trailing P/E Ratio 45.25
- Forward P/E Ratio 45.25
- P/E Growth 45.25
- Net Income $62.04 M
Income Statement
Quarterly
Annual
Latest News of PGNY
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Progyny's (NASDAQ:PGNY) earnings have declined over three years, contributing to shareholders 73% loss
Progyny Inc. investors have faced significant losses, with a 73% decline in three years and a recent 47% drop. Despite a recent uptick, the CEO's modest pay and a potential growth trend are positive s...
By Yahoo! Finance | 1 month ago -
Here's What Affected Progyny's (PGNY) Share Price in Q2
Fred Alger Management's "Alger Weatherbie Specialized Growth Fund" investor letter for Q2 2024 reveals strong performance, with Class A shares outperforming the Russell 2500 Growth Index. Progyny, Inc...
By Yahoo! Finance | 2 months ago -
Insider Sale: President Michael Sturmer Sells Shares of Progyny Inc (PGNY)
President Michael Sturmer sold 9,030 shares of Progyny Inc on July 16, 2024, now owning 362,583 shares. The company has seen significant insider selling with no buys in the past year....
By Yahoo! Finance | 4 months ago
